Ignite Creation Date:
2025-12-25 @ 12:28 AM
Ignite Modification Date:
2025-12-25 @ 10:34 PM
Study NCT ID:
NCT01512667
Status:
COMPLETED
Last Update Posted:
2018-08-28
First Post:
2012-01-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Pharmacokinetic Assessment of Single-Dose Odanacatib (MK-0822) in Subjects With Severe Renal Insufficiency (MK-0822-067)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2012-08-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-08-22
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-13
First Submit QC Date:
None
Study First Post Date:
2012-01-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-06-12
Results First Submit QC Date:
None
Results First Post Date:
2018-02-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-30
Last Update Post Date:
2018-08-28
Last Update Post Date Type:
ACTUAL